https://www.selleckchem.com/pr....oducts/vazegepant-hy
6, p = 0.004; CCI ≥2 HR 3.6, p = 0.001). CONCLUSION This study demonstrates the prognostic relevance of comorbidities classified by CCI and HCT-CI in patients with DLBCL undergoing curative treatment with R-CHOP. A structured evaluation of comorbidities might refine prognostication alongside currently used prognostic parameters, namely age, and should be evaluated in prospective trials.Candida albicans and Staphylococcus aureus specifically often resulted in biofilm-associated diseases, ranging from superficial mucosal
Like
Comment
Share
